Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases

被引：1
作者：
Gabelli, Maria [1 ,2 ]
Stepensky, Polina [3 ]
Ottaviano, Giorgio [1 ]
Mullanfiroze, Khushnuma [1 ]
Lazareva, Arina [1 ]
Zaidman, Irina [3 ]
Even-Or, Ehud [3 ]
Lucchini, Giovanna [1 ]
Chiesa, Robert [1 ]
Silva, Juliana [1 ]
Adams, Stuart [4 ]
Kricke, Susanne [4 ]
Finch, Maria [1 ]
Hill, Annette [1 ]
Mead, Rachel [1 ]
Veys, Delphine [5 ]
Schejter, Yael Dinur [3 ]
Eddin, Adeeb Naser [3 ]
Worth, Austen [6 ]
Amrolia, Persis J. [1 ]
Rao, Kanchan [1 ]
机构：
[1] Great Ormond St Hosp Sick Children, Bone Marrow Transplantat, London, England
[2] Univ Padua, Pediat Hematol Oncol & Stem Cell Transplantat, Padua, Italy
[3] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Ctr, Bone Marrow Transplantat, Jerusalem, Israel
[4] Great Ormond St Hosp Sick Children, Specialist Integrated Hematol & Malignancy Diagno, Hematol, London, England
[5] St Johns Coll, Cambridge, England
[6] Great Ormond St Hosp Sick Children, Immunol, London, England
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 01期
关键词：
SURVIVAL;
D O I：
10.1038/s41409-022-01844-x
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [41] The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease
    Stadler, Michael
    Hambach, Lothar
    Dammann, Elke
    Diedrich, Helmut
    Kamal, Haytham
    Hamwi, Iyas
    Schultze-Florey, Christian
    Varvenne, Michael
    Ehrlich, Steve
    Buchholz, Stefanie
    Koenecke, Christian
    Beutel, Gernot
    Weissinger, Eva M.
    Krauter, Juergen
    Eder, Matthias
    Hertenstein, Bernd
    Ganser, Arnold
    ANNALS OF HEMATOLOGY, 2023, 102 (09) : 2529 - 2542
  • [42] Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation
    Milano, Antonio
    Lando, Giuliana
    Di Maggio, Giulia
    Cornacchini, Giorgia
    Grillo, Giovanni
    Cairoli, Roberto
    Rossini, Silvano
    Crocchiolo, Roberto
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (03)
  • [43] Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia
    Gadalla, Shahinaz M.
    Wang, Tao
    Dagnall, Casey
    Haagenson, Michael
    Spellman, Stephen R.
    Hicks, Belynda
    Jones, Kristine
    Katki, Hormuzd A.
    Lee, Stephanie J.
    Savage, Sharon A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2276 - 2282
  • [44] Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: A prospective study
    Porrata, Luis F.
    Inwards, David J.
    Ansell, Stephen M.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Gastineau, Dennis A.
    Litzow, Mark R.
    Winters, Jeffrey L.
    Markovic, Svetomir N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (07) : 807 - 816
  • [45] Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma
    Galvez-Silva, Jorge
    Maher, Ossama M.
    Park, Minjeong
    Liu, Diane
    Hernandez, Fiorela
    Tewari, Priti
    Nieto, Yago
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (08) : 1276 - 1281
  • [46] Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma
    Kim, H
    Sohn, HJ
    Kim, SE
    Kang, HJ
    Park, S
    Kim, S
    Kim, WK
    Lee, JS
    Suh, C
    BONE MARROW TRANSPLANTATION, 2004, 34 (01) : 43 - 49
  • [47] Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma
    H Kim
    H-J Sohn
    S-E Kim
    H-J Kang
    S Park
    S Kim
    W-K Kim
    J-S Lee
    C Suh
    Bone Marrow Transplantation, 2004, 34 : 43 - 49
  • [48] The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT
    Martin Schmidt-Hieber
    Gloria Tridello
    Per Ljungman
    Malgorzata Mikulska
    Nina Knelange
    Didier Blaise
    Gerard Socié
    Liisa Volin
    Nicole Blijlevens
    Nathalie Fegueux
    Ibrahim Yakoub-Agha
    Edouard Forcade
    Johan Maertens
    Patrice Chevallier
    Jakob Passweg
    Jan Cornelissen
    Nigel Russell
    Charles Craddock
    Jean Henri Bourhis
    Tony Marchand
    Péter Reményi
    Jean Yves Cahn
    Mauricette Michallet
    Silvia Montoto
    Nicolaus Kröger
    Bertram Glaß
    Jan Styczynski
    Annals of Hematology, 2019, 98 : 1755 - 1763
  • [49] The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT
    Schmidt-Hieber, Martin
    Tridello, Gloria
    Ljungman, Per
    Mikulska, Malgorzata
    Knelange, Nina
    Blaise, Didier
    Socie, Gerard
    Volin, Liisa
    Blijlevens, Nicole
    Fegueux, Nathalie
    Yakoub-Agha, Ibrahim
    Forcade, Edouard
    Maertens, Johan
    Chevallier, Patrice
    Passweg, Jakob
    Cornelissen, Jan
    Russell, Nigel
    Craddock, Charles
    Bourhis, Jean Henri
    Marchand, Tony
    Remenyi, Peter
    Cahn, Jean Yves
    Michallet, Mauricette
    Montoto, Silvia
    Kroeger, Nicolaus
    Glass, Bertram
    Styczynski, Jan
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1755 - 1763
  • [50] Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen
    Marsh, Rebecca A.
    Rao, Marepalli B.
    Gefen, Aharon
    Bellman, Denise
    Mehta, Parinda A.
    Khandelwal, Pooja
    Chandra, Sharat
    Jodele, Sonata
    Myers, Kasiani C.
    Grimley, Michael
    Dandoy, Christopher
    El-Bietar, Javier
    Kumar, Ashish R.
    Leemhuis, Tom
    Zhang, Kejian
    Bleesing, Jack J.
    Jordan, Michael B.
    Filipovich, Alexandra H.
    Davies, Stella M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (08) : 1460 - 1470
12345